Incyte Financials - Benzinga

Incyte Corp

INCYNASDAQ

Trade with Public

Trade with Public

$123.53

-0.36-0.29%

Ult. Agg.: Sep 28, 10:22 AM

Panoramica Notizie Previsioni utili Eventi Obiettivi di prezzoDati finanziariSentiment Azionariato Confronta Opzioni Rapporto azionario

Incyte Financials

Incyte (INCY) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

Incyte Analysts Raise Their Forecasts After Upbeat Q2 Results

Incyte Corp. (INCY) reported strong Q2 results, raised full-year sales guidance. CEO cites sales growth, pipeline progress, and business development. Analysts maintain buy ratings with price target increases.

Avi Kapoor

Incyte Says It's No Longer A One-Drug Story

Incyte (INCY) Q2 earnings beat estimates with $1.67B revenue, $3.09 EPS. Full-year sales guidance raised. Shares rally to new 52-week high.

Vandana Singh

PRO
Incyte Q2 Adj. EPS $3.09 Beats $2.12 Estimate, Sales $1.663B Beat $1.460B Estimate

Incyte (NASDAQ:INCY) reported quarterly earnings of $3.09 per share which beat the analyst consensus estimate of $2.12 by 45.75 percent. This is a 96.82 percent increase over earnings of $1.57 per share from the same

Benzinga Newsdesk

PRO
Incyte Raises FY2026 Sales Guidance from $4.770B-$4.940B to $5.130B-$5.260B vs $5.712B Est

Incyte (NASDAQ:INCY) raises FY2026 sales outlook from $4.770 billion-$4.940 billion to $5.130 billion-$5.260 billion vs $5.712 billion estimate.

Benzinga Newsdesk

PRO
Incyte Sees FY2026 Sales $4.770B-$4.940B vs $5.569B Est

Incyte (NASDAQ:INCY) sees FY2026 sales of $4.770 billion-$4.940 billion vs $5.569 billion analyst estimate.

Benzinga Newsdesk

PRO
CORRECTION: Incyte Q1 Adj. EPS $1.81 Beats $1.37 Estimate, Sales $1.273B Beat $1.217B Estimate.

Incyte (NASDAQ:INCY) reported quarterly earnings of $1.81 per share which beat the analyst consensus estimate of $1.37 by 32.12 percent. This is a 56.03 percent increase over earnings of $1.16 per share from the same

Benzinga Newsdesk

© 2026 Benzinga | All Rights Reserved